Tirofiban and eptifibatide, but not abciximab, induce leukocyte-platelet aggregation

被引：0
|
作者：
Furman, MI
Krueger, LA
Frelinger , AL
Barnard, MR
Mascelli, MA
Nakada, MT
Michelson, AD
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Centocor Inc, Malvern, PA USA
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3591
引用
收藏
页码：681 / 681
页数：1
相关论文
共 50 条
  • [1] Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function
    Lev, EI
    Osende, JI
    Richard, MF
    Robbins, JA
    Delfin, JA
    Rodriguez, O
    Sharma, SK
    Jayasundera, T
    Badimon, JJ
    Marmur, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) : 847 - 855
  • [2] Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interaction
    Bertram, U
    Moser, M
    Nordt, T
    Peter, K
    Ruef, J
    CIRCULATION, 2001, 104 (17) : 651 - 651
  • [3] Evidence of leukocyte-platelet aggregation after stroke and reperfusion
    Ritter, L
    Orozco, J
    Stempel, K
    Mendoza, S
    Coull, B
    McDonagh, P
    FASEB JOURNAL, 2001, 15 (04) : A36 - A36
  • [4] Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates
    Moser, M
    Bertram, U
    Peter, K
    Bode, C
    Ruef, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (04) : 586 - 592
  • [5] Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban
    Kereiakes, DJ
    Lorenz, T
    Young, JJ
    Kukielka, G
    Mueller, MN
    Nanniazzi-Alaimo, L
    Phillips, DR
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2001, 12 (02) : 123 - 127
  • [6] Differential Effects of Citrate Versus PPACK Anticoagulation on Measured Platelet Inhibition by Abciximab, Eptifibatide and Tirofiban
    Dean J. Kereiakes
    Todd Lorenz
    John J. Young
    Gilbert Kukielka
    Michele N. Mueller
    Lisa Nanniazzi-Alaimo
    David R. Phillips
    Journal of Thrombosis and Thrombolysis, 2001, 12 : 123 - 127
  • [7] Antiplatelet effect of abciximab, tirofiban and eptifibatide with coronary stent placement
    Neumann, FJ
    Hochholzer, W
    Pogatsa-Murray, G
    Gawaz, M
    Schömig, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 34A - 35A
  • [8] A randomized study on the level of platelet function inhibition by abciximab, eptifibatide and tirofiban during elective PTCA.
    Leebeek, FWG
    van den Brand, MJBM
    van Vliet, HHDM
    van Asperen, H
    Simoons, ML
    BLOOD, 2001, 98 (11) : 53A - 54A
  • [9] Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
    Neumann, FJ
    Hochholzer, W
    Pogatsa-Murray, G
    Schömig, A
    Gawaz, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) : 1323 - 1328
  • [10] Leukocyte-platelet co-aggregation hallmarks the severity of diabetic microangiopathy
    Rauch, U
    Hesse, S
    Schwippert, B
    Tschoepe, D
    DIABETES, 1996, 45 : 974 - 974
12345